agilon health director awarded 2,133 RSUs

WILLIAMS RONALD A reported acquisition or exercise transactions in this Form 4 filing. agilon health, inc. director Ronald A. Williams received a grant of 2,133 restricted stock units of common stock, with no cash price per share reported.

Rhea-AI Filing Summary

WILLIAMS RONALD A reported acquisition or exercise transactions in this Form 4 filing.

agilon health, inc. director Ronald A. Williams received a grant of 2,133 restricted stock units of common stock, with no cash price per share reported. These units vest in full on June 2, 2027, subject to his continued service as a director.

After this award, Williams beneficially owns 149,141 shares of agilon health common stock, including restricted stock units. The holdings figure reflects a 1-for-25 reverse stock split of the company’s issued and outstanding common stock that became effective on March 30, 2026.

Insider Trade Summary

Grant/Award: 2,133 shares

Grant/Award 1 txn

Insider WILLIAMS RONALD A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,133	$0.00	$0.00

Holdings After Transaction: Common Stock — 149,141 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director
2. F2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
3. F3. Includes restricted stock units.

Key Figures

RSU grant size: 2,133 units Vesting date: June 2, 2027 Post-transaction holdings: 149,141 shares +2 more

5 metrics

RSU grant size 2,133 units Restricted stock units granted to director on June 2, 2026

Vesting date June 2, 2027 RSUs vest in full on this date, subject to continued service

Post-transaction holdings 149,141 shares Beneficially owned common stock, including RSUs, after grant

Reverse stock split ratio 1-for-25 Reverse split of issued and outstanding common stock

Reverse split effective date March 30, 2026 Date reverse stock split became effective

Key Terms

Restricted stock units, reverse stock split, beneficially owned

3 terms

Restricted stock units financial

"Restricted stock units that vest in full on June 2, 2027"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

reverse stock split financial

"reflects the 1 for 25 reverse stock split of the Issuer's issued"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

beneficially owned financial

"The amount of securities beneficially owned following the reported transaction"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did agilon health (AGL) report for Ronald A. Williams?

agilon health reported that director Ronald A. Williams received 2,133 restricted stock units of common stock. The award carries no cash purchase price and represents equity-based compensation that will vest over time rather than an open-market stock purchase or sale.

When do Ronald A. Williams’s new restricted stock units at agilon health (AGL) vest?

The 2,133 restricted stock units vest in full on June 2, 2027, provided Williams continues serving as a director. Vesting means the units convert into common shares he can own outright, aligning his compensation with long-term company performance over that period.

How many agilon health (AGL) shares does Ronald A. Williams own after this Form 4 transaction?

Following the grant, Ronald A. Williams beneficially owns 149,141 shares of agilon health common stock, including restricted stock units. This total reflects his direct equity stake after the award and already factors in the company’s previously executed reverse stock split.

How did agilon health’s reverse stock split affect Ronald A. Williams’s reported holdings?

The filing notes a 1-for-25 reverse stock split effective March 30, 2026. Williams’s post-transaction holdings of 149,141 shares are reported after adjusting for this split, meaning earlier share counts were consolidated so each 25 pre-split shares became one post-split share.

Is Ronald A. Williams’s agilon health (AGL) Form 4 transaction a market buy or sell?

The Form 4 shows a grant of restricted stock units, coded as an “A” transaction for award or other acquisition. This is compensation-based and not an open-market buy or sell, so it does not directly reflect a trading decision in the public market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 09:56 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILLIAMS RONALD A

(Last) (First) (Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OHIO 43082

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		A		2,133(1)	A	$0	149,141(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director

2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

3. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)